SN · Pharma and healthcare · one day
Smith & Nephew (SN): news on Thursday 29 October 2026
News from the 24 hours to Thursday morning, 29 October 2026.
Tone of the day
−5.8negative
−5.8
Relevant headlines1
Stories1
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Fri 23 Oct | −3.7 | 7 |
| Sat 24 Oct | −5.7 | 21 |
| Sun 25 Oct | −2.0 | 3 |
| Mon 26 Oct | −1.2 | 4 |
| Tue 27 Oct | −5.3 | 4 |
| Wed 28 Oct | +7.0 | 1 |
| Thu 29 Oct | −5.8 | 1 |
1 story · 1 headline · strongest first
Pharma and healthcare on 29 OctoberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Smith & Nephew faces weak US implant sales −5.81 headline today · A piece looks at Smith & Nephew's struggles with US implants. | ||
| −5.8 | Coverage centres on the company facing soft demand for its implant products in America.}], | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.